Motor dexterity in schizophrenia spectrum disorders: Familiality and association with polygenic risk scores.
Autores de IDIVAL
Autores ajenos al IDIVAL
- Sevilla-Ramos M
- Ladera V
- García-García R
- Murillo-García N
Unidades
Abstract
OBJECTIVE: Motor dexterity (MD), a potential endophenotype for schizophrenia spectrum disorders, might exhibit familiality, showing greater similarity among biological relatives. Moreover, MD deficits in first-episode psychosis (FEP) patients may be related to their increased genetic liability for schizophrenia (SCZ). We examined MD familiality and its association with genetic risk for SCZ. We controlled disorder severity by analysing FEP patients with SCZ and other psychosis (OP) separately. METHODS: Cross-sectional family study including 133 FEP patients and 244 of their first-degree relatives and 202 healthy controls. We used the grooved pegboard test to assess MD and estimated polygenic scores for SCZ (PGS-SCZ) in the participants. Statistical analysis included linear mixed models and intraclass correlation coefficient (ICC) RESULTS: MD has low familiality (ICC = 0.10) in the whole sample of FEP patients and their relatives. In SCZ families, there was a trend toward MD familiality (p = 0.063). In OP families, MD was familial only in unaffected relatives (ICC = 0.33). FEP patients showed the highest PGS-SCZ, followed by parents, siblings, and healthy controls. No significant association was found between PGS-SCZ and MD. CONCLUSIONS: MD shows low familiality in FEP patients. Further research is needed to assess differences by severity of the disorder. Genetic risk for SCZ is not directly linked to MD but may influence it indirectly through neurodevelopment. PGS-SCZ was not associated with MD deficits in FEP patients, possibly reflecting the limited capacity of this tool to capture shared genetic liability between these traits. Environmental factors, in conjunction with genetic predisposition, may significantly contribute to MD development.
Copyright © 2025. Published by Elsevier Inc.
Datos de la publicación
- ISSN/ISSNe:
- 0278-5846, 1878-4216
- Tipo:
- Article
- Páginas:
- 111406-111406
- PubMed:
- 40436363
Progress In Neuro-Psychopharmacology & Biological Psychiatry Pergamon-Elsevier Science Ltd.
Citas Recibidas en Web of Science: 1
Documentos
- No hay documentos
Filiaciones
Filiaciones no disponibles
Keywords
- Endophenotype; Familiality; First episode psychosis; Genetic; Motor dexterity
Campos de Estudio
Financiación
Proyectos asociados
10PAFIP neurocognición: Estudio longitudinal a largo plazo (10 años) del funcionamiento cognitivo en pacientes con psicosis del espectro de esquizofrenia
Investigador Principal: María Rosa Ayesa Arriola
PI14/00918 . INSTITUTO DE SALUD CARLOS III. . 2015
PAFIP-FAMILIAS: estudio del funcionamiento neuropsicológico y variantes genéticas asociadas en familiares de pacientes con trastornos del espectro de la esquizofrenia
Investigador Principal: María Rosa Ayesa Arriola
PI17/00221 . INSTITUTO DE SALUD CARLOS III. . 2018
Adaptación y validación de la bateria cognitiva Brief Assessment of Cognition App (BAC App) y del Virtual Reality Assessment of Functional Capacity Tool (VRFCAT) para su uso en España
Investigador Principal: María Rosa Ayesa Arriola
PI20/00066 . INSTITUTO DE SALUD CARLOS III. . 2021
Estudio en descendientes de padres con trastornos del espectro de la esquizofrenia: continuación del proyecto PAFIP-FAMILIAS e incorporación del discurso como biomarcador de psicosis.
Investigador Principal: María Rosa Ayesa Arriola
PI23/00076 . INSTITUTO DE SALUD CARLOS III. . 2024
Prevención y detección precoz de los trastornos del espectro de la esquizofrenia a través del discurso: desarrollo de instrumentos para identificar signos del lenguaje y motores utilizando inteligencia artificial (QUIJOTE)
Investigador Principal: María Rosa Ayesa Arriola
CNS2022-136110 . Ministerio de Economía y Competitividad. MINECO . 2023
Actividad Investigadora